Amirmahdi Taromiha

Dr. Amirmahdi Taromiha

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2025 in Cardiology
Verified
Journal Article
Closed access
SMSeyed Mohsen Mirhosseini
Seyed Mohsen Mirhosseini
MRMahdi Rezaei
Mahdi Rezaei
Masood SoltanipurMasood Soltanipur
Masood Soltanipur
HYHossein Yarmohammadi
Hossein Yarmohammadi
ESErfan Soroush
Erfan Soroush
SSSeyed Davar Siadat
Seyed Davar Siadat
Introduction: Imbalances in gut microbiota are linked to chronic diseases, including heart failure, where shifts in microbial composition are evident in patients with reduced ejection fraction (HFrEF). This study compared gut microbiome profiles between HFrEF patients and healthy controls and explored potential links between microbiome composition and patient survival over 6 and 12 months. Methods: In this longitudinal case-control study, 20 HFrEF patients and 40 healthy controls were recruited, with stool samples collected for gut microbiome analysis. Patients were followed for 6 and 12 months to assess survival. Gut microbiome composition was analyzed using real-time PCR for specific bacterial taxa. Statistical analyses were performed using R to compare HFrEF and control groups and draw the ROC curve to predict survival at 6 and 12 months. Results: HFrEF patients showed a significantly lower abundance of all bacterial taxa, except for A. muciniphila. Decreased levels of Prevotella, F. prausnitzii, Firmicutes, and Bacteroidetes, as well as a lower Firmicutes/Bacteroidetes (F/B) ratio, were notable in HFrEF patients, with specific taxa correlating with clinical features like ascites and vitamin D levels. Most bacterial taxa and the F/B ratio could distinguish HFrEF patients from controls, though none effectively predicted survival outcomes at 6 or 12 months. Conclusion: The study demonstrates that patients with HFrEF exhibit a distinct gut microbiome profile compared to healthy individuals. While specific gut bacteria were effective in distinguishing HFrEF patients from healthy controls, their ability to predict survival outcomes was limited, highlighting the need for further research into the role of the gut microbiome in the progression and prognosis of heart failure.

2 April 2025 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
Masood SoltanipurMasood Soltanipur
Masood Soltanipur
HYHossein Yarmohammadi
Hossein Yarmohammadi
SASeyed Fatah Mahdavi Anari
Seyed Fatah Mahdavi Anari
MNMohammadreza Karimi Nemch
Mohammadreza Karimi Nemch
ATAmirmahdi Taromiha
Amirmahdi Taromiha
SSSeyed Davar Siadat
Seyed Davar Siadat

9 June 2025 in Journal of Academic Ethics
Verified
Journal Article
Closed access
PDF file
MFMohammad Shahrabi Farahani
Mohammad Shahrabi Farahani
HYHossein Yarmohammadi
Hossein Yarmohammadi
MIMaryam Iranzadasl
Maryam Iranzadasl
Masood SoltanipurMasood Soltanipur
Masood Soltanipur
BDBabak Daneshfard
Babak Daneshfard
ATAmirmahdi Taromiha
Amirmahdi Taromiha

1 January 2025
Verified
Journal Article
Closed access
HYHessam Yaghmaei
Hessam Yaghmaei
ATAmirmahdi Taromiha
Amirmahdi Taromiha
SNseyed ali nojoumi
seyed ali nojoumi
Masood SoltanipurMasood Soltanipur
Masood Soltanipur
SSSina Shahshenas
Sina Shahshenas
SSSeyed Davar Siadat
Seyed Davar Siadat